Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza

Background: Infectious respiratory pathogens like SARS-CoV-2 and influenza frequently mutate, leading to the emergence of variants. This necessitates continuous updates to FDA-approved vaccines with booster shots targeting the circulating variants. Vaccine hesitancy and needle injections create inco...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sharon Vijayanand, Smital Patil, Priyal Bagwe, Revanth Singh, Emmanuel Adediran, Martin J. D’Souza
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-03-01
Edice:	Vaccines
Témata:	intranasal vaccine infectious diseases microparticles immunogenicity combination vaccine COVID-19
On-line přístup:	https://www.mdpi.com/2076-393X/13/3/282
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!